Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
Trump tells FDA to fund itself fully through industry fees; Astra’s CEO dumps Teva offer
This
week, Phispers brings you lots of regulatory news from the US, where the Trump
administration h
Top drugs by sales in 2016: Who sold the blockbuster drugs?
The year 2016 finished with a whimper insofar as mergers and acquisitions (M&As) were concerned.
Capsugel’s U.S. plant has data-integrity issues, billion dollar Chinese bid for Indian sterile manufacturer, Pfizer & Mylan’s dermatology bet
This week’s Phispers has regulatory and M&A news from across the world as Pfizer ends its
Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?
The year 2015 has gone down
in history as a record year for mergers and acquisitions in the pharmace
Phispers: Ranbaxy whistleblower takes Indian govt to court; Merck claims US $ 3 billion from Gilead & more
This week, Pharmaceutical
Whispers (Phispers) looks at Ranbaxy whistleblower’s public interest
Dr. Reddy’s expansion plans for API production
Unrelated to the inspection of
the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe
